Immunology and Drug Discovery

Immunology involves the development and application of methods of bioinformatics, mathematics and statistics for the study of immune system biology. Through drug discovery mechanism new drugs can be discovered and designed and the causes of the diseases can be analyzed and ways could be found to tackle them. The modern drug discovery process integrates the understanding of the molecular basis for a disease with crucial understanding of how potential drug molecules interact with particular disease targets and the whole organism. Bioinformatics is a growing field which can explore the causes of diseases at the molecular level, explain the occurrence of the diseases from the genetic angle and make use of computer techniques to diminish the scope of study and enhance the efficiency of the results so as to curtail the cost and time.

  • Innovative methods and techniques in immunology
  • Immune cells & proteins
  • Clinical biomarkers

Related Conference of Immunology and Drug Discovery

July 13-14, 2018

13th International Conference on Structural Biology

Toronto | Ontario | Canada
15-16 August 2018

16th Asia Pacific Biotechnology Congress

Singapore
August 16-17, 2018

5th Annual Congress on Plant & Soil Science

London, UK
August 27-28, 2018

5th International Conference on Glycobiology, Lipids & Proteomics

Toronto, Ontario, Canada
August 27-28, 2018

3rd International Conference on Molecular Biology & Nucleic Acids

Toronto, Ontario, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018

4th International Conference on Biochemistry & Biophysics

Los Angeles, California, USA
Nov 19-20, 2018

15th World Congress on Structural Biology

Lisbon, Portugal
December 05-06, 2018

4th International Conference on Genetic and Protein Engineering

Chicago, Illinois, USA

Immunology and Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in